Publication | Open Access
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
86
Citations
39
References
2023
Year
These results suggest that statins deserve further study as well-tolerated, inexpensive drugs that may enhance responses to PD-1 checkpoint blockade and other immunotherapies for HNSCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1